Starpharma creates slow release soluble DEP® remdesivir nanoparticle
1 September 2020 DEP® remdesivir has been created to expand the potential application of remdesivir, by creating a long-acting version which could be administered subcutaneously rather than by intravenous infusion in hospital DEP® remdesivir is a highly water-soluble nanoparticle formulation…
Trillion data points to identify disease-causing genes
1 September 2020 Researchers from CSIRO, Australia’s national science agency, have accomplished a world-first by processing one trillion points of genomic data through VariantSpark, an artificial intelligence-based platform, which can help pinpoint the location of specific disease-causing genes…
Breakthrough discovery paves the way for preventing sugar-induced liver disease
3 September 2020 Release date 25 August 2020 A team of international researchers including Monash University academics has discovered that, contrary to previous belief, fructose causes liver toxicity by changing the barrier function of the intestine. This new…
Nucleus Network begins dosing for third COVID-19 vaccine trial
1 September 2020 Australia’s largest Phase 1 Clinical trials specialist, Nucleus Network, has today commenced dosing the first human participants for the Phase 1/2 trial COVID-19 Vaccine trial in collaboration with the vaccine’s developer Serum Institute of India…
Living with COVID-19 – an assessment of the pandemic’s ongoing impact on Australian Healthcare (IQVIA)
Date posted 1 September 2020 IQVIA ANZ business has just released; Living with COVID-19 – an assessment of the pandemic’s ongoing impact on Australian Healthcare. This is the second in a special series of reports, which offer IQVIA’s…
Luina Bio announces new Bio-manufacturing GMP and development facility expansion
1 September 2020 Highlights Small scale GMP manufacturing suites open in Q3 2020 500L tech transfer and process development site aim for open Q4 2020 This precedes the next phase with Luina planning to commission a 10,000m2 late…
4DMedical Release FY20 Full Year Results
1 September 2020 Release date 28 August 2020 4DMedical Limited, a medical technology company focused on commercialising its patented respiratory imaging technology, today announces its full year results for the financial year ended 30 June 2020 (FY20). During…
Burnet Institute: Focus on milestones, not time frames for COVID exit
31 August 2020 Burnet Director and CEO Professor Brendan Crabb AC believes Victoria’s exit strategy from stage four COVID-19 restrictions should be measured in terms of milestones, not time frames – and the key benchmark is the elimination…
Exopharm Raises $10m in Well Supported Placement
31 August 2020 Release date 27 August 2020 Exopharm to place 41,666,667 shares at $0.24 per share to institutional and high net worth investors to raise $10m before costs Shares to be issued in two tranches with tranche…
St Vincent’s Hospital on the Park leads new charge in Victoria’s collective fight against COVID-19
31 August 2020 Release date 26 August 2020 St Vincent’s has welcomed patients at its newest hospital to help manage the escalating demand on Victoria’s healthcare system caused by the COVID-19 pandemic. The Victorian Government called on St…
Lessons from the COVID-19 frontline captured in UniMelb Health Worker Voices project
31 August 2020 Release date 24 August 2020 Voice memos from health workers in Australia and around the world are being collected via a private WhatsApp chat to capture their experience of the coronavirus (COVID-19) pandemic and improve…
Patient Enrolment Opens in Cynata COVID-19 Clinical Trial
31 August 2020 Release date 24 August 2020 Cynata Therapeutics Limited (ASX: CYP), a leading clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that the MEND (MEseNchymal coviD-19) Trial is now open for patient enrolment.…
